Cargando…

Hematologists and nephrologists working together: moving forward with a new integrated care model for blood-related malignancies?

Detalles Bibliográficos
Autores principales:	Niscola, Pasquale, Caravita, Tommaso, Tatangelo, Paola, Siniscalchi, Agostina, de Fabritiis, Paolo, Palumbo, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641515/ https://www.ncbi.nlm.nih.gov/pubmed/29043238 http://dx.doi.org/10.5045/br.2017.52.3.218

Ejemplares similares

Azacitidine in Chronic Myelomonocytic Leukemia: An Effective and Manageable Approach
por: Tendas, Andrea, et al.
Publicado: (2014)

Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis
por: Niscola, Pasquale, et al.
Publicado: (2013)

Proton-Coupled Electron Transfer: Moving Together and Charging Forward
por: Hammes-Schiffer, Sharon
Publicado: (2015)

Advancing together and moving forward: Combination gene and cellular immunotherapies
por: Priceman, Saul J., et al.
Publicado: (2022)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report
por: Vischini, Gisella, et al.
Publicado: (2011)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

Survival of the FITTER: Moving Forward Together for a Premier Journal in Vascular Surgery
por: Min, Seung-Kee
Publicado: (2019)

Identifying the link between multiple myeloma and neurofibromatosis type I
por: Rago, Angela, et al.
Publicado: (2020)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
por: Molica, Matteo, et al.
Publicado: (2021)

Medicine together with humanities and media: An MHM model to move forward for health communication studies
por: Li, Zhenyi, et al.
Publicado: (2020)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

Primary mixed-type autoimmune hemolytic anemia concomitant with acute splanchnic venous thrombosis of idiopathic origin in a young woman: an unexplained association
por: Scaramucci, Laura, et al.
Publicado: (2013)

Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
por: Niscola, Pasquale, et al.
Publicado: (2013)

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia
por: Scaramucci, Laura, et al.
Publicado: (2013)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Acute Mesenteric Thrombosis: A Hematologist Perspective
por: Moiz, Bushra, et al.
Publicado: (2020)

Cancer associated thrombosis: Which lessons for the hematologist?
por: Noble, Simon
Publicado: (2018)

Moving chemical sciences together
por: Chambaud, Gilberte
Publicado: (2021)

Preventive and Rescue Work: A Forward Move in London
Publicado: (1922)

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
por: Crisà, Elena, et al.
Publicado: (2021)

Moving forward in the treatment of cholangiocarcinoma
por: Manzia, Tommaso M, et al.
Publicado: (2021)

Moving forward
por: Li, Li
Publicado: (2020)

Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018)

Treatment of Chronic Kidney Disease: Moving Forward
por: Garibotto, Giacomo, et al.
Publicado: (2022)

Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy
por: Niscola, Pasquale, et al.
Publicado: (2014)

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome
por: Niscola, Pasquale, et al.
Publicado: (2013)

Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent
por: Niscola, Pasquale, et al.
Publicado: (2015)

Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency
por: Scaramucci, Laura, et al.
Publicado: (2016)

Regaining the response to erythropoietin following azacitidine in chronic myelomonocytic leukemia previously evolved from refractory anemia
por: Niscola, Pasquale, et al.
Publicado: (2015)

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy
por: Niscola, Pasquale, et al.
Publicado: (2014)

Universal iron fortification of foods: the view of a hematologist
por: Martins, José Murilo
Publicado: (2012)

Cancer-associated thrombosis (CAT) - New challenges for the hematologist
por: Brækkan, Sigrid
Publicado: (2018)

Introduction to a review series on COVID-19 and the hematologist
por: Ortel, Thomas L., et al.
Publicado: (2022)

Myosins pull together to move cargo
por: Leslie, Mitch
Publicado: (2007)

Pure erythroid leukemia in advanced breast cancer
por: Niscola, Pasquale, et al.
Publicado: (2014)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
por: Tendas, Andrea, et al.
Publicado: (2016)

Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
por: Niscola, Pasquale, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_afnghnfe8jnnedmae7dqojq83k